{
  "compound": "Nabilone",
  "condition": "PARKINSONS",
  "effect_size": "Medium (d = 0.58)",
  "study_type": "RCT",
  "source": "NORML:PD_RCT_002",
  "participants": "7 PD patients with severe dyskinesia",
  "year": 2001,
  "notes": "Nabilone for Parkinson's Disease Levodopa-Induced Dyskinesia",
  "confidence": "medium",
  "abstract": "Nabilone: 22% reduction in total dyskinesia score (p=0.02); Duration of beneficial effect: 4+ hours"
}